Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 41

Trial Status

Completed1
Recruiting1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT06285279Phase 1Recruiting
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
ANCA-associated VasculitisIgG4-Related DiseasesLupus Nephritis+1 more
PrincipalinvestigatorStart date: 2024-03-04
NCT03123406Phase 4Completed
Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Hyperparathyroidism; Secondary, Renal
StudychairStart date: 2017-04-19

Research Network

Collaboration Network

22 collaborators·69 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Li Hao

The Second Hospital of Anhui Medial University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Yisheng Ling

Zhongshan Hospital Xiamen University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Junwei Yang

Second Affiliated Hospital of Nanjing Medical University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Chaosheng Chen

First Affiliated Hospital of Wenzhou Medical University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Jiazhuang Lou

The First Affiliated Hospital with Nanjing Medical University

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Xiaonong Chen

Ruijin Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Aihua Zhang

Peking University Third Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Xuemei Li

Peking Union Medical College Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Qiang He

Sichuan Provincial People's Hospital

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Guanqing Xiao

First People's Hospital of Foshan

Related
1 trials

Shared therapeutic areas:

Hyperparathyroidism; Secondary, Renal

Worked with same sponsors:

Kyowa Kirin China Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06285279Phase 1PrincipalInvestigator

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

ANCA-associated VasculitisIgG4-Related DiseasesLupus Nephritis+1 more
Recruiting
NCT03123406Phase 4StudyChair

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Hyperparathyroidism; Secondary, Renal
Completed

All 2 trials loaded